Getting the human papillomavirus vaccine was associated with a substantially lower risk of invasive cervical cancer, a new study shows.
Conducted in Sweden, the study examined data for 1.6 million girls and women who were 10 to 30 years old during the period of 2006 through 2017. The study results were published in The New England Journal of Medicine.
Researchers found 19 women who had received the quadrivalent HPV vaccine were diagnosed with cervical cancer, compared to 538 women who had not received the vaccine.
The cumulative rate of cervical cancer was 47 cases per 100,000 people among women who had been vaccinated and 94 cases per 100,000 people among those who had not been vaccinated.